Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy
- PMID: 3524432
- PMCID: PMC284164
- DOI: 10.1128/AAC.29.5.845
Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy
Abstract
Strains of Escherichia coli, Enterobacter aerogenes, and Enterobacter cloacae that were resistant to ceftazidime (MIC greater than 16 micrograms/ml) but susceptible to BMY 28142 (MIC less than 4 micrograms/ml) were found to contain higher levels of beta-lactamase activity (50- to 3,340-fold) than control strains of the corresponding species. Ceftazidime was at least as resistant as BMY 28142 to hydrolysis by these enzymes. However, the apparent Ki of BMY 28142 for each enzyme was larger (8- to greater than 20-fold) than that of ceftazidime; i.e., the affinity of these enzymes for BMY 28142 appeared to be lower than that for ceftazidime. Thus, BMY 28142 was affected less than ceftazidime by a mechanism of resistance that depends, at least in part, on the relative affinities of cephalosporins for the beta-lactamases of these species. These results indicate that the affinity between a beta-lactamase and a cephalosporin may be a distinguishing factor in the evaluation of beta-lactamase-resistant cephalosporins and suggest that affinity can play a major role in susceptibility to highly beta-lactamase-resistant cephalosporins.
Similar articles
-
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.Antimicrob Agents Chemother. 1985 May;27(5):679-82. doi: 10.1128/AAC.27.5.679. Antimicrob Agents Chemother. 1985. PMID: 3893316 Free PMC article.
-
The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.J Antimicrob Chemother. 1986 Apr;17(4):441-52. doi: 10.1093/jac/17.4.441. J Antimicrob Chemother. 1986. PMID: 3486862
-
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.Antimicrob Agents Chemother. 1989 Apr;33(4):498-502. doi: 10.1128/AAC.33.4.498. Antimicrob Agents Chemother. 1989. PMID: 2499250 Free PMC article.
-
Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.Drugs. 2019 Feb;79(3):271-289. doi: 10.1007/s40265-019-1055-2. Drugs. 2019. PMID: 30712199 Review.
-
[Cefepime (maxipime), large spectrum 4th generation cephalosporin, resistant to beta-lactamases].Chirurgia (Bucur). 2001 Nov-Dec;96(6):547-52. Chirurgia (Bucur). 2001. PMID: 12731231 Review. Romanian.
Cited by
-
Clinical importance of inducible beta-lactamases in gram-negative bacteria.Eur J Clin Microbiol. 1987 Aug;6(4):435-8. doi: 10.1007/BF02013106. Eur J Clin Microbiol. 1987. PMID: 3311737 Review.
-
Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa.Antimicrob Agents Chemother. 1998 Jul;42(7):1610-9. doi: 10.1128/AAC.42.7.1610. Antimicrob Agents Chemother. 1998. PMID: 9660993 Free PMC article.
-
Cloning, sequence analyses, expression, and distribution of ampC-ampR from Morganella morganii clinical isolates.Antimicrob Agents Chemother. 1999 Apr;43(4):769-76. doi: 10.1128/AAC.43.4.769. Antimicrob Agents Chemother. 1999. PMID: 10103179 Free PMC article.
-
Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.Antimicrob Agents Chemother. 1990 Feb;34(2):337-42. doi: 10.1128/AAC.34.2.337. Antimicrob Agents Chemother. 1990. PMID: 2109581 Free PMC article.
-
Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria.Infection. 1991 May-Jun;19(3):186-9. doi: 10.1007/BF01643250. Infection. 1991. PMID: 1889877
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources